EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V116. A total of 15 filers reported holding EFFECTOR THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $20 | -99.1% | 16,666 | 0.0% | 0.00% | -100.0% |
Q1 2024 | $2,333 | -5.1% | 16,666 | 0.0% | 0.00% | -50.0% |
Q4 2023 | $2,458 | +94.0% | 16,666 | 0.0% | 0.00% | +100.0% |
Q3 2023 | $1,267 | -51.4% | 16,666 | 0.0% | 0.00% | -50.0% |
Q2 2023 | $2,608 | +21.1% | 16,666 | 0.0% | 0.00% | +100.0% |
Q1 2023 | $2,153 | -21.0% | 16,666 | 0.0% | 0.00% | -50.0% |
Q4 2022 | $2,727 | -9.1% | 16,666 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $3,000 | 0.0% | 16,666 | 0.0% | 0.00% | +100.0% |
Q2 2022 | $3,000 | -57.1% | 16,666 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $7,000 | -53.3% | 16,666 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $15,000 | -44.4% | 16,666 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $27,000 | – | 16,666 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Evolution Capital Management LLC | 50,000 | $10,000 | 0.02% |
ARISTEIA CAPITAL, L.L.C. | 1,557,474 | $264,000 | 0.01% |
WHITEBOX ADVISORS LLC | 298,145 | $61,000 | 0.00% |
LITTLEJOHN & CO LLC | 16,666 | $3,000 | 0.00% |
MMCAP International Inc. SPC | 145,941 | $30,000 | 0.00% |
CVI Holdings, LLC | 49,738 | $10,000 | 0.00% |
Parallel Advisors, LLC | 64,166 | $13,000 | 0.00% |
III Capital Management | 41,795 | $7,000 | 0.00% |
Tower Research Capital LLC (TRC) | 23 | $0 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 56,083 | $11,000 | 0.00% |